The objective of the Fund is to achieve absolute returns through targeted investment strategies independent of United Kingdom market conditions or indices.
Name | % Net Assets |
---|---|
Babcock Intl Group Ord Gbp0.60 | 6.4% |
Melrose Ord Gbp0.002 | 6.1% |
GLAXOSMITHKLINE | 4.3% |
RSA INSURANCE GROUP PLC | 4.0% |
IMPERIAL TOBACCO GROUP | 3.1% |
HOWDEN JOINERY GROUP PLC | 3.1% |
MORRISON(WM.)SUPERMARKETS | 2.8% |
MORGAN CRUCIBLE CO | 2.6% |
Astrazeneca Ord Usd0.25 | 2.3% |
Compass Group Ord Gbp0.10 | 2.1% |
Key | % Net Assets |
---|---|
Babcock Intl Group Ord Gbp0.60 | 6.4% |
Melrose Ord Gbp0.002 | 6.1% |
GLAXOSMITHKLINE | 4.3% |
RSA INSURANCE GROUP PLC | 4.0% |
Other | 79.2% |
Date | 15-Jun-2020 |
---|---|
NAV | 1.05p |
Currency | GBP |
Change | 0.009p |
% | -0.85% |
YTD change | 1.05p |
YTD % | n/a |
Fund Inception | 18/07/2008 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research